Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.

Kuhn L, Semrau K, Ramachandran S, Sinkala M, Scott N, Kasonde P, Mwiya M, Kankasa C, Decker D, Thea DM, Aldrovandi GM.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):132-6. doi: 10.1097/QAI.0b013e3181ab6d5e.

PMID:
19506483
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.

Coovadia A, Hunt G, Abrams EJ, Sherman G, Meyers T, Barry G, Malan E, Marais B, Stehlau R, Ledwaba J, Hammer SM, Morris L, Kuhn L.

Clin Infect Dis. 2009 Feb 15;48(4):462-72. doi: 10.1086/596486.

PMID:
19133804
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Preventing mother-to-child transmission of HIV in resource-limited settings: the Elizabeth Glaser Pediatric AIDS Foundation experience.

Spensley A, Sripipatana T, Turner AN, Hoblitzelle C, Robinson J, Wilfert C; Elizabeth Glaser Pediatric AIDS Foundation Prevention of Mother-to-Child Transmission of HIV Group.

Am J Public Health. 2009 Apr;99(4):631-7. doi: 10.2105/AJPH.2007.114421. Epub 2008 Aug 13.

PMID:
18703458
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
[PubMed - indexed for MEDLINE]
Free Article
5.

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.

Chi BH, Sinkala M, Mbewe F, Cantrell RA, Kruse G, Chintu N, Aldrovandi GM, Stringer EM, Kankasa C, Safrit JT, Stringer JS.

Lancet. 2007 Nov 17;370(9600):1698-705. Epub 2007 Nov 7. Erratum in: Lancet. 2008 Feb 23;371(9613):650.

PMID:
17997151
[PubMed - indexed for MEDLINE]
6.

A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe.

Zijenah LS, Kadzirange G, Rusakaniko S, Kufa T, Gonah N, Tobaiwa O, Gwanzura C, Matsikire E, Katzenstein DA.

Cent Afr J Med. 2006 Jan-Feb;52(1-2):1-8.

PMID:
17892232
[PubMed - indexed for MEDLINE]
7.

Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?

McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, Eshleman SH.

Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S56-63. Review.

PMID:
17825651
[PubMed - indexed for MEDLINE]
8.

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.

Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F; Ghent Group on HIV in Women and Children.

Int J Epidemiol. 2007 Oct;36(5):1009-21. Epub 2007 May 28. Review.

PMID:
17533166
[PubMed - indexed for MEDLINE]
Free Article
9.

Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine.

Chi BH, Sinkala M, Stringer EM, Cantrell RA, Mtonga V, Bulterys M, Zulu I, Kankasa C, Wilfert C, Weidle PJ, Vermund SH, Stringer JS.

AIDS. 2007 May 11;21(8):957-64.

PMID:
17457089
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Response to antiretroviral therapy after a single, peripartum dose of nevirapine.

Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, Chand F, Makhema J, Moffat C, Asmelash A, Ndase P, Arimi P, van Widenfelt E, Mazhani L, Novitsky V, Lagakos S, Essex M.

N Engl J Med. 2007 Jan 11;356(2):135-47.

PMID:
17215531
[PubMed - indexed for MEDLINE]
Free Article
11.

Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.

Loubser S, Balfe P, Sherman G, Hammer S, Kuhn L, Morris L.

AIDS. 2006 Apr 24;20(7):995-1002.

PMID:
16603851
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group.

JAMA. 2006 Mar 8;295(10):1152-60. Erratum in: JAMA. 2006 Oct 18;296(15):1842.

PMID:
16522836
[PubMed - indexed for MEDLINE]
13.

Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.

Eshleman SH, Guay LA, Wang J, Mwatha A, Brown ER, Musoke P, Mmiro F, Jackson JB.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):24-9.

PMID:
16123677
[PubMed - indexed for MEDLINE]
14.

Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH.

J Infect Dis. 2005 Jul 1;192(1):24-9. Epub 2005 Jun 1.

PMID:
15942890
[PubMed - indexed for MEDLINE]
Free Article
15.

Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.

Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V; ANRS 1201/1202 DITRAME PLUS Study Group.

AIDS. 2005 Feb 18;19(3):309-18.

PMID:
15718842
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, Ariyadej S, Leenasirimakul P, Hammer S, Lallemant M; Perinatal HIV Prevention Trial Group.

N Engl J Med. 2004 Jul 15;351(3):229-40. Epub 2004 Jul 9.

PMID:
15247339
[PubMed - indexed for MEDLINE]
Free Article
17.

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.

Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V; Perinatal HIV Prevention Trial (Thailand) Investigators.

N Engl J Med. 2004 Jul 15;351(3):217-28. Epub 2004 Jul 9.

PMID:
15247338
[PubMed - indexed for MEDLINE]
Free Article
18.

Implementing a rural programme of prevention of mother-to-child transmission of HIV in Zimbabwe: first 18 months of experience.

Perez F, Mukotekwa T, Miller A, Orne-Gliemann J, Glenshaw M, Chitsike I, Dabis F.

Trop Med Int Health. 2004 Jul;9(7):774-83.

PMID:
15228487
[PubMed - indexed for MEDLINE]
Free Article
19.

Preventing mother-to-child HIV transmission in a developing country: the Dominican Republic experience.

Perez-Then E, Peña R, Tavarez-Rojas M, Peña C, Quiñonez S, Buttler M, Ammann A, Hernández W, Goyanes M, Miguez MJ, Shor-Posner G; PMTCT Group.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):506-11.

PMID:
14657762
[PubMed - indexed for MEDLINE]
20.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.

Lancet. 2003 Sep 13;362(9387):859-68.

PMID:
13678973
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk